In the design of abuse-deterrent formulations (ADFs), pharmaceutical strategies that do not modify the physical and chemical properties of opioid dosage forms should be investigated. Among these, four major drug abusing factors, including particle size by physical modification, swellability, dissolution rate, and solvent extraction, were mainly characterized for evaluating abuse deterrence of narcotics. Tramadol hydrochloride (TMD) was chosen as a model drug. In this study, the frequently used eight generally recognized as safe (GRAS)-listed pharmaceutical excipients, including polyvinyl alcohol (PVA), hydroxypropyl methylcellulose (HPMC 4,000, HPMC 100,000), xanthan gum (XG), cellulose acetate (CA), polyethylene oxide (PEO), carbomer 940 NF, and Compritol® 888 ATO, were selected as abuse deterring agents and used to prepare TMD-loaded tablet. A new abuse-deterrent index (ADI) for compressed TMD-loaded tablets was originally defined and considered as an index of drug abuse deterrence, based on the assumption that it was proportional to particle size and swellability but inversely proportional to dissolution and solvent extraction rates after assigning the categorized five scale scores (one to five) to the four experimental data. The resulting ADI of the selected eight abuse deterring agents in deionized water was given in decreasing order: HPMC 4000 > carbomer 940 > Compritol® 888 ATO > XG > PVA > HPMC 100,000 > PEO, and CA while in 40% hydro-alcoholic solution in the decreasing order: carbomer 940 > HPMC 4,000 ≒ XG > PVA > HPMC 100,000 > PEO > Compritol® 888 ATO > CA. Interestingly, the HPMC 4,000 and carbomer 940 showed the highest ADI and gave drug abuse deterrent potential. This study could provide a pharmaceutical strategy that utilizes a variety of abuse-deterring agents and resist to extraction solvents in designing drug abuse-deterrent formulations and establishing their standard guidelines for regulatory authorities.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijpharm.2021.120726 | DOI Listing |
Aust J Prim Health
January 2025
Drug and Alcohol Services, Northern Sydney Local Health District, NSW Health, St Leonards, NSW, Australia; and Specialty of Addiction Medicine, Northern Clinical School, The University of Sydney, St Leonards, NSW, Australia; and National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia.
Background Despite the paramount importance of oral health, individuals undergoing treatment for opioid use disorder face unique challenges beyond traditional addiction care. This qualitative study explores the challenges Opioid Treatment Program (OTP) clients in Australia encounter when accessing oral health care, aiming to understand the underlying factors and identify effective strategies for integrating oral health into an OTP. Methods Semi-structured interviews were conducted with OTP clients, OTP clinicians and oral health clinicians using tested interview guides.
View Article and Find Full Text PDFPLoS One
December 2024
Collective for Midwifery, Child and Family Health, School of Nursing and Midwifery, Faculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Background: The mistreatment of women during maternity care hinders quality care globally and deter women from seeking health services. To implement necessary actions, it is essential to explore instances of mistreatment, their factors and negative outcomes. This study explores the narratives of mistreatment experienced by women, its drivers, as well as the consequences of mistreatment.
View Article and Find Full Text PDFMMW Fortschr Med
December 2024
Heinrich-Braun-Klinikum Zwickau, ChA der Klinik f. Psychiatrie u. Psychotherapie, Karl-Keil-Str. 35, 8060, Zwickau, Deutschland.
Background: Many former top GDR athletes are still suffering from the consequences of the GDR doping system, which has so far been dealt with by the sports historian Giselher Spitzer in particular with questionnaire surveys. The present study analyzes medical reports of n = 107 recognized GDR doping victims, categorizes the symptoms in analogy to Spitzer's survey and compares both surveys.
Method: All specialist reports, hospital and rehabilitation stay reports of the recognized doping victims (56 ♀ , 51 ♂ ) provided were reviewed, analyzed, adapted to Spitzer's previously known rubrication, presented descriptively, tabularly and graphically and statistically tested (e.
J Gen Intern Med
November 2024
Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, CA, USA.
Background: Individuals with opioid use disorder have high rates of hospital admissions, which represent a critical opportunity to engage patients and initiate medications for opioid use disorder (MOUD). However, few patients receive MOUD and, even if MOUD is initiated in the hospital, patients may encounter barriers to continuing MOUD in the community.
Objective: Describe hospital providers' experiences and perspectives to inform initiatives and policies that support hospital-based MOUD initiation and continuation in community treatment programs.
Res Involv Engagem
October 2024
Faculty of Medical Sciences, Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Background: Working alongside patients and the public to shape and engage with research, Patient and Public Involvement and Engagement (PPIE), facilitates more impactful research outcomes. The UK Standards for Public Involvement provides a framework for conducting PPIE; however, they do not refer directly to ethical conduct. Research ethics involve the moral principles that govern researchers' actions, and securing ethical approval from a research ethics committee is necessary before starting a study.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!